Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome.
Autor: | Bener, Abdulbari, Dogan, Muzeyyen, Barakat, Lolwa, Al-Hamaq, Abdulla O. A. A. |
---|---|
Zdroj: | Journal of Primary Care & Community Health; Jul2014, Vol. 5 Issue 3, p180-187, 8p |
Databáze: | Complementary Index |
Externí odkaz: |